Comments to the National Healthcare Security Administration (NHSA) on 2023 National Reimbursement Drug List (NRDL) Adjustment Workplan
2023-06-15 | Beijing, Shanghai
On 15th June, European Chamber Pharmaceutical Working Group submitted comments to the National Healthcare Security Administration (NHSA) on the 2023 National Reimbursement Drug List (NRDL) Adjustment Workplan.
Member companies offered detailed suggestions on optimising the NRDL adjustment mechanism.